Statement of Organization, Functions, and Delegations of Authority, 60528-60529 [05-20792]
Download as PDF
60528
Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices
system of records from the system
manager at the above address.
RECORD REVIEW PROCEDURES:
Requests from individuals for access
to their records should be addressed to
the system manager.
PROCEDURE TO CONTEST A RECORD:
GSA rules for access to systems of
records, contesting the contents of
systems of records, and appealing initial
determinations are published at 41 CFR
Part 105–64.
RECORD SOURCES:
The sources are individuals, other
employees, supervisors, other agencies,
management officials, and non-Federal
sources such as private firms.
[FR Doc. 05–20759 Filed 10–17–05; 8:45 am]
BILLING CODE 6820–34–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
2005 White House Conference on
Aging Policy Committee
Administration on Aging, HHS.
Notice of meeting.
AGENCY:
ACTION:
SUMMARY: Pursuant to Section 10(a) of
the Federal Advisory Committee Act as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the eighth Policy
Committee meeting concerning
planning for the 2005 White House
Conference on Aging. The meeting will
be open to the public, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should inform the
contact person listed below in advance
of the meeting. This notice is being
published less than 15 days prior to the
meeting due to scheduling problems.
DATES: The meeting will be held
Tuesday, October 25, 2005, from 1 p.m.
to 4 p.m.
ADDRESSES: The meeting will be held in
the Atrium Ballroom at The Washington
Court Hotel, 525 New Jersey Avenue,
NW., Washington, DC 20001–1527.
FOR FURTHER INFORMATION CONTACT: Kim
Butcher at (301) 443–2887, or e-mail at
https://www.Kim.Butcher@whcoa.gov.
Registration is not required. Seating is
on a first come, first-served basis.
SUPPLEMENTARY INFORMATION: Pursuant
to the Older Americans Act
Amendments of 2000 (Pub. L. 106–501,
November 2000), the Policy Committee
will meet to finalize discussions and
VerDate Aug<31>2005
17:22 Oct 17, 2005
Jkt 208001
planning, including a vote on the
Annotated Agenda, for the 2005
WHCoA that will be held from
December 11 through 14, 2005 at the
Marriott Wardman Park Hotel in
Washington, DC.
Dated: October 13, 2005.
Edwin L. Walker,
Deputy Assistant Secretary for Policy and
Programs.
[FR Doc. 05–20834 Filed 10–17–05; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 58431–32, dated
October 6, 2005) is amended to reflect
the reorganization of the National
Immunization Program.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Revise the functional statement for
the Office of the Director (CJ1), National
Immunization Program Office (CJ) by
inserting after item (12) the following:
(13) creates and executes information
science and technology strategic plans
to provide the Program with related
services (e.g., hardware/software
consultation, database development and
management, etc.) and ensures
compliance with CDC IT infrastructure
and requirements.
Delete in their entirety the following
titles and functional statements of the
National Immunization Program Office
(CJ):
Data Management Division (CJ2)
Systems Operation and Design Activity
(CJ2–2)
Immunization Registry Support Branch
(CJ22)
Assessment Branch (CJ23)
Statistical Analysis Branch (CJ24)
Following the title and functional
statement for the Health Services
Research and Evaluation Branch (CJ46),
Immunization Services Division (CJ4),
insert the following:
Immunization Registry Support
Branch (CJ47). (1) Provides quality
assurance for each program study,
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
survey, and surveillance system
evaluation of immunization registries at
the state and local level to build an
infrastructure to raise and sustain
immunization coverage in children; (2)
facilitates information flow among
Program, divisions, grantees,
professional organizations, and private
contractors regarding immunization
registry systems development through
regular conference calls, clearinghouse
function, up-to-date Web sites, and an
annual national conference; (3)
establishes complex health and
technical functional specifications and
standards for immunization registry
systems developed by state and local
health department personnel and
commercial software developers to be
used throughout public and private
health delivery systems; (4) acts as a
catalyst to build the political and
professional will and legal environment
to facilitate the development and
implementation of immunization
registries; (5) fosters evidence-based
enhancements of immunization
registries through on-site standardized
evaluations and promoting research that
identifies factors associated with system
success and failure; (6) promotes the
secure, automated exchange of
immunization records between
immunization registries by fostering
consensus on, and implementation of,
the required protocols and standards; (7)
advocates for immunization registries in
the development and maintenance of
public health data models and
participates in the development of such
data models; and (8) formulates longrange plans and proposals for future
systems modification, and facilitates the
use of standards and expert guidance to
assure national and international health
information systems are responsive to
agency and constituent needs.
Assessment Branch (CJ48). (1)
Performs coding and editing, and
arranges for data input either in-house
or through an outside vendor; (2)
collaborates with the National Center for
Health Statistics, and other Centers as
necessary, in the conduct of household
probability surveys, random digit
dialing surveys, and other types of
surveys to measure immunization
coverage; (3) collects, tabulates and
analyzes immunization assessment data,
including sample survey data, census
counts at school entrance, monthly and/
or quarterly vaccine administration
reports, and the biologic reports from
manufacturers; (4) designs sample
surveys for epidemiologic investigations
fro childhood and adult vaccinepreventable diseases; (5) develops and
maintains liaison with external groups
E:\FR\FM\18OCN1.SGM
18OCN1
Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices
regarding assessments; (6) directs the
assessment of immunization levels for
the national population and specific
population sub-segments; (7) determines
the most appropriate implementation
procedure for data management
activities operations for the NIS and
NHIS Immunization coverage data; (8)
provides documented data sets upon
completion of studies and surveys; (9)
establishes, implements, monitors, and
maintains the standards and procedures
for immunization-related data collection
for data analysis for NIS data; and (10)
establishes and evaluates data quality
control measures to assure that all
Program studies, surveys, and
surveillance systems adhere to the
established standards and procedures
from data collection to the point of data
analysis.
Dated: April 28, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
Editorial Note: This document was
received at the Office of the Federal Register
October 13, 2005.
[FR Doc. 05–20792 Filed 10–17–05; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 58431–58432,
dated October 6, 2005) is amended to
reorganize the National Personal
Protective Technology Laboratory,
National Institute for Occupational
Safety and Health.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the title for the National
Personal Protective Technology
Laboratory (CCL) delete the functional
statement and insert the following:
The mission of the National Personal
Protective Technology Laboratory
(NPPTL) is to prevent work-related
injury and illness by ensuring the
development, certification, deployment,
VerDate Aug<31>2005
17:22 Oct 17, 2005
Jkt 208001
and use of personal protective
equipment and fully integrated,
intelligent ensembles. To accomplish its
mission, NPPTL: (1) Conducts a variety
of laboratory and field research relating
to the development and evaluation of
innovative personal protective
technologies and equipment; (2)
researches and develops criteria,
standards and guidelines relating to
personal protective technology (PPT)
performance, quality, reliability and
efficacy; (3) directs and carries out the
NIOSH respirator approval program and
related laboratory, field, quality, and
records activities; (4) produces and
disseminates research findings,
technical information, training
materials, performance criteria, and
recommendations for using personal
protective equipment to improve
protection of workers; (5) conducts
surveillance of hazards at worksites for
which protective technologies and
equipment are used to protect workers,
and studies patterns of personal
protective technology (PPT) use; and (6)
develops studies and assesses the
effectiveness of communications and
training approaches and technologies
relating to PPT.
Technology Evaluation Branch
(CCLE). (1) Administers Department of
health and Human Services 42 CFR part
84 respirator approval program
including processing respirator approval
applications; i.e., certifying
performance, quality, reliability, and
efficacy of respiratory protection
devices in accordance with Federal
regulations and NIOSH policy; (2)
evaluates and maintains official records
on NIOSH-approved respirators; (3)
evaluates quality control plans,
including in-plant manufacturing-site
quality system audits, and monitors the
quality and performance of certified
respirators; (4) evaluates personal
protective technologies and equipment;
(5) investigates field problems
associated with NIOSH-certified
respirators and other PPE; (6)
recommends NIOSH activities to
address product non-conformance such
as NIOSH approval rescission, product
recalls or retrofits, and public
notification of potentially unsafe PPE
products; (7) provides technical
assistance on the selection, use,
maintenance, and operation of
respiratory protective equipment and
other PPE; (8) conducts PPT failure
investigations and analyses, and
recommends criteria to improve PPT,
and (9) recommends user guidelines,
including cautions, limitations, and
restrictions of use.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
60529
Technology Research Branch (CCLG).
(1) Encourages and conducts research
related to innovative technologies for
new products; (2) conducts laboratory
and field research of methods and PPT
performance, quality, reliability, and
efficacy, especially for new or emerging
hazards and recommends criteria to
improve PPT; (3) investigates emerging
hazards and personal exposures to
identify worker PPT needs and
technology gaps; (4) conducts research
for the effective integration of various
personal protective technologies and
equipment; (5) recommends
performance, quality, reliability, and
efficacy criteria; (6) conducts hypothesis
testing-based research; (7) studies and
improves human/technology interfaces;
and (8) conducts research into the
physiologic and psychologic stressors
and worker responses to protective
technologies and equipment.
Policy and Standards Development
Branch (CCLH). (1) Develops and
promulgates new approval PPE-related
standards and regulations; (2) identifies
where research is needed to support
new standards, regulations, and policies
relating to NIOSH-certified respirators
and other PPE; (3) recommends NIOSH
policy relating to the approval of
respirators, including approval policies
for innovative respirator features; (4)
assesses research findings and translates
them into effective recommendations for
NIOSH policy, regulations, and auditing
practices, especially for new PPE
technologies or special applications of
these technologies; (5) holds public
meetings to solicit information
concerning users needs and the
feasibility of specific technologies; (6)
participates in national and
international PPE standard setting
committees and establishes a national/
international database of relevant
standards, and (7) determines the public
financial and legal impacts of Federal
regulation revision.
Delete in their entirety the following
titles and functional statements for the
NPPTL: Respirator Branch (CCC2),
Technology Research Branch (CCC3),
Surveillance Communications and
Training Branch (CCC4).
Dated: June 3, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 05–20790 Filed 10–17–05; 8:45am]
BILLING CODE 4160–18–M
E:\FR\FM\18OCN1.SGM
18OCN1
Agencies
[Federal Register Volume 70, Number 200 (Tuesday, October 18, 2005)]
[Notices]
[Pages 60528-60529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20792]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 70 FR 58431-32, dated October 6, 2005) is
amended to reflect the reorganization of the National Immunization
Program.
Section C-B, Organization and Functions, is hereby amended as
follows:
Revise the functional statement for the Office of the Director
(CJ1), National Immunization Program Office (CJ) by inserting after
item (12) the following: (13) creates and executes information science
and technology strategic plans to provide the Program with related
services (e.g., hardware/software consultation, database development
and management, etc.) and ensures compliance with CDC IT infrastructure
and requirements.
Delete in their entirety the following titles and functional
statements of the National Immunization Program Office (CJ):
Data Management Division (CJ2)
Systems Operation and Design Activity (CJ2-2)
Immunization Registry Support Branch (CJ22)
Assessment Branch (CJ23)
Statistical Analysis Branch (CJ24)
Following the title and functional statement for the Health
Services Research and Evaluation Branch (CJ46), Immunization Services
Division (CJ4), insert the following:
Immunization Registry Support Branch (CJ47). (1) Provides quality
assurance for each program study, survey, and surveillance system
evaluation of immunization registries at the state and local level to
build an infrastructure to raise and sustain immunization coverage in
children; (2) facilitates information flow among Program, divisions,
grantees, professional organizations, and private contractors regarding
immunization registry systems development through regular conference
calls, clearinghouse function, up-to-date Web sites, and an annual
national conference; (3) establishes complex health and technical
functional specifications and standards for immunization registry
systems developed by state and local health department personnel and
commercial software developers to be used throughout public and private
health delivery systems; (4) acts as a catalyst to build the political
and professional will and legal environment to facilitate the
development and implementation of immunization registries; (5) fosters
evidence-based enhancements of immunization registries through on-site
standardized evaluations and promoting research that identifies factors
associated with system success and failure; (6) promotes the secure,
automated exchange of immunization records between immunization
registries by fostering consensus on, and implementation of, the
required protocols and standards; (7) advocates for immunization
registries in the development and maintenance of public health data
models and participates in the development of such data models; and (8)
formulates long-range plans and proposals for future systems
modification, and facilitates the use of standards and expert guidance
to assure national and international health information systems are
responsive to agency and constituent needs.
Assessment Branch (CJ48). (1) Performs coding and editing, and
arranges for data input either in-house or through an outside vendor;
(2) collaborates with the National Center for Health Statistics, and
other Centers as necessary, in the conduct of household probability
surveys, random digit dialing surveys, and other types of surveys to
measure immunization coverage; (3) collects, tabulates and analyzes
immunization assessment data, including sample survey data, census
counts at school entrance, monthly and/or quarterly vaccine
administration reports, and the biologic reports from manufacturers;
(4) designs sample surveys for epidemiologic investigations fro
childhood and adult vaccine-preventable diseases; (5) develops and
maintains liaison with external groups
[[Page 60529]]
regarding assessments; (6) directs the assessment of immunization
levels for the national population and specific population sub-
segments; (7) determines the most appropriate implementation procedure
for data management activities operations for the NIS and NHIS
Immunization coverage data; (8) provides documented data sets upon
completion of studies and surveys; (9) establishes, implements,
monitors, and maintains the standards and procedures for immunization-
related data collection for data analysis for NIS data; and (10)
establishes and evaluates data quality control measures to assure that
all Program studies, surveys, and surveillance systems adhere to the
established standards and procedures from data collection to the point
of data analysis.
Dated: April 28, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
Editorial Note: This document was received at the Office of the
Federal Register October 13, 2005.
[FR Doc. 05-20792 Filed 10-17-05; 8:45 am]
BILLING CODE 4160-18-M